Internal Medicine & Immunology
Immunotherapy beyond cancer
Expanding immunotherapies beyond oncology requires a different development playbook. Discover practical strategies to mitigate risk, improve patient retention, and accelerate clinical development in chronic disease populations.
Global regulatory strategies for immunology
Innovation in immunology is reshaping how therapies are developed and approved worldwide. This whitepaper provides practical insight into how regulatory frameworks are evolving across key regions and how development programs can be structured to support long term success.
Internal Medicine & Immunology blogs and media contributions
-
Blog: The new era of COPD drug development: How precision medicine is reshaping clinical strategy
COPD drug development is entering a new era, with biologics and biomarker-driven approaches transforming patient identification, evidence generation, and asset differentiation in an increasingly competitive market.
-
Media article: Aging with HIV: What the next major challenge is for drug development
As people with HIV live longer due to ART, new challenges are emerging. Aging with HIV is linked to higher risks of comorbidities, chronic inflammation, and drug interactions, while gaps in clinical trial inclusion and care models highlight the need for more integrated, patient-centered treatment strategies.
-
Blog: Pushing boundaries in idiopathic pulmonary fibrosis clinical research
The landscape of IPF research is evolving and early-stage biopharmaceutical teams need a new roadmap to success. We offer strategies to meet the challenges to develop new treatments.
-
Blog: Complexities of running clinical trials in retinal disorders and ways to overcome them
In this blog, we will explore the complexities of running clinical trials in retinal disorders and discuss ways to overcome these challenges.
-
Media article: Telemedicine is yet to overcome diversity challenges in dermatology clinical trials
This article explores the benefits and challenges of telemedicine in dermatology clinical trials.
-
Blog: Multidiagnostic approaches for patient selection biomarkers in immuno-oncology
Advances in our understanding of cancer biology and the tumour microenvironment (TME), have led to the development of personalised drug and therapy designs to better prevent disease progression and relapse
